From nitrate to NO: potential effects of nitrate-reducing bacteria on systemic health and disease

• Published in: European journal of medical research Vol. 28; no. 1; pp. 1 - 425
• Main Authors: Liu, Hongyu, Huang, Yisheng, Huang, Mingshu, Wang, Min, Ming, Yue, Chen, Weixing, Chen, Yuanxin, Tang, Zhengming, Jia, Bo
• Format: Journal Article
• Language: English
• Published: London BioMed Central Ltd 11-10-2023; BioMed Central; BMC
• Subjects: Bacteria; Biological activity; Blood vessels; Campylobacter; Diet; Dietary supplements; Disease; Enzymes; Esophageal microflora; Esophagus; Gastrointestinal microflora; Gastrointestinal system; Homeostasis; Human body; Medical research; Medicine, Experimental; Metabolism; Microbiota; Microbiota (Symbiotic organisms); Nitrate; Nitrate reductase; Nitrate-reducing bacteria; Nitrates; Nitric oxide; Oral microflora; Physiology; Review; Signal transduction
• ISSN: 2047-783X; 0949-2321; 2047-783X
• DOI: 10.1186/s40001-023-01413-y

Current research has described improving multisystem disease and organ function through dietary nitrate (DN) supplementation. They have provided some evidence that these floras with nitrate (NO.sub.3.sup.-) reductase are mediators of the underlying mechanism. Symbiotic bacteria with nitrate reductase activity (NRA) are found in the human digestive tract, including the mouth, esophagus and gastrointestinal tract (GT). Nitrate in food can be converted to nitrite under the tongue or in the stomach by these symbiotic bacteria. Then, nitrite is transformed to nitric oxide (NO) by non-enzymatic synthesis. NO is currently recognized as a potent bioactive agent with biological activities, such as vasodilation, regulation of cardiomyocyte function, neurotransmission, suppression of platelet agglutination, and prevention of vascular smooth muscle cell proliferation. NO also can be produced through the conventional l-arginine-NO synthase (l-NOS) pathway, whereas endogenous NO production by l-arginine is inhibited under hypoxia-ischemia or disease conditions. In contrast, exogenous NO.sub.3.sup.-/NO.sub.2.sup.-/NO activity is enhanced and becomes a practical supplemental pathway for NO in the body, playing an essential role in various physiological activities. Moreover, many diseases (such as metabolic or geriatric diseases) are primarily associated with disorders of endogenous NO synthesis, and NO generation from the exogenous NO.sub.3.sup.-/NO.sub.2.sup.-/NO route can partially alleviate the disease progression. The imbalance of NO in the body may be one of the potential mechanisms of disease development. Therefore, the impact of these floras with nitrate reductase on host systemic health through exogenous NO.sub.3.sup.-/NO.sub.2.sup.-/NO pathway production of NO or direct regulation of floras ecological balance is essential (e.g., regulation of body homeostasis, amelioration of diseases, etc.). This review summarizes the bacteria with nitrate reductase in humans, emphasizing the relationship between the metabolic processes of this microflora and host systemic health and disease. The potential effects of nitrate reduction bacteria on human health and disease were also highlighted in disease models from different human systems, including digestive, cardiovascular, endocrine, nervous, respiratory, and urinary systems, providing innovative ideas for future disease diagnosis and treatment based on nitrate reduction bacteria. Keywords: Oral microflora, Esophageal microflora, Gastrointestinal microflora, Nitrate-reducing bacteria, Nitrate reductase, Nitrate, Nitrite, NO